
Among patients with #mCRPC, 43% did not receive bone-modifying agents, with use declining in recent years despite guideline recommendations. #Oncology
ja.ma/4wCfTPJ

English
JAMA Network Open
25K posts

@JAMANetworkOpen
JAMA Network Open is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.






































